Category REGENERATIVE MEDICINE

FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene

Action FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS). Qalsody is an antisense oligonucleotide that targets SOD1 mRNA to reduce the synthesis of SOD1 protein. The approval was based on a reduction in plasma neurofilament light (NfL), a blood-based

Read More


FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older

Read More


Attracting Stem Cells and Facilitating Bone Regeneration by Adhesive Protein

A joint research team of POSTECH, Kyungpook National University, and Korea University Anam Hospital developed an osteogenic barrier coating material that maximizes the effect of guided bone regeneration (GBR) for implant placements. One of the key factors of success in a dental implant is the condition of the periodontium around the implant. A higher long-term

Read More


Researchers of MGH Bioengineer an Endocrine Pancreas for Type 1 Diabetes

Key Takeaways In people with type 1 diabetes, the body’s immune system attacks and destroys insulin-producing β cells that control blood glucose levels and are part of a group of cells in the pancreas called pancreatic islets. In research published in Cell Reports Medicine, a team led by investigators at Massachusetts General Hospital (MGH), a founding member

Read More


Injectable disc allograft tissue provides significant, long-term relief for chronic back pain, finds research

A minimally invasive treatment that injects allograft disk tissue into the spine to relieve pain associated with degenerative disk disease provides significant improvement in pain and function over a sustained period, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting in Phoenix, March 4–9. The treatment, known as viable disk

Read More


Researchers of UEF unraveled new mechanisms behind articular cartilage healing after injury

Understanding how the knee joint environment affects cartilage cells is crucial for joint health. Knowledge of cell-driven cartilage degeneration mechanisms can support the development of effective pharmaceutical interventions for osteoarthritis. The burden of musculoskeletal diseases, such as osteoarthritis, is increasingly affecting patients’ quality of life and bringing enormous costs to health care. In efforts to

Read More


The Texas Heart Institute Delivers a New First in Heart Failure Treatment Using Cell Therapy

New Cell Therapy Offers Potential Treatment Option for Patients With Chronic Heart Failure Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction. The therapy benefited patients by improving the heart’s pumping ability, as measured by

Read More


Duke-NUS and NHCS scientists first in the world to regenerate diseased kidney

Blocking an immune-regulating protein reverses the damage caused by acute and chronic kidney disease, a preclinical study suggests. Led by scientists at Duke-NUS Medical School and the National Heart Centre Singapore, researchers in Singapore and Germany have found that renal tubular cells, which line the tiny tubes inside kidneys, release a scar-regulating protein called interleukin-11

Read More